241 related articles for article (PubMed ID: 16109105)
1. A Clinico-pathological study on the effect of vincristine on transmissible venereal tumour in dogs.
Nak D; Nak Y; Cangul IT; Tuna B
J Vet Med A Physiol Pathol Clin Med; 2005 Sep; 52(7):366-70. PubMed ID: 16109105
[TBL] [Abstract][Full Text] [Related]
2. Canine transmissible venereal tumour: a morphological and immunohistochemical study of 11 tumours in growth phase and during regression after chemotherapy.
Gonzalez CM; Griffey SM; Naydan DK; Flores E; Cepeda R; Cattaneo G; Madewell BR
J Comp Pathol; 2000 May; 122(4):241-8. PubMed ID: 10805977
[TBL] [Abstract][Full Text] [Related]
3. Effective Treatment of Transmissible Venereal Tumors in Dogs with Vincristine and IL2.
DEN Otter W; Hack M; Jacobs JJ; Tan JF; Rozendaal L; VAN Moorselaar RJ
Anticancer Res; 2015 Jun; 35(6):3385-91. PubMed ID: 26026099
[TBL] [Abstract][Full Text] [Related]
4. Successful management of metastatic transmissible venereal tumour to skin of mammary region.
Varughese EE; Singla VK; Ratnakaran U; Gandotra VK
Reprod Domest Anim; 2012 Dec; 47 Suppl 6():366-9. PubMed ID: 23279540
[TBL] [Abstract][Full Text] [Related]
5. Transmissible venereal tumor: a retrospective study of 29 cases.
Rogers KS; Walker MA; Dillon HB
J Am Anim Hosp Assoc; 1998; 34(6):463-70. PubMed ID: 9826280
[TBL] [Abstract][Full Text] [Related]
6. Predictive factors for the regression of canine transmissible venereal tumor during vincristine therapy.
Scarpelli KC; Valladão ML; Metze K
Vet J; 2010 Mar; 183(3):362-3. PubMed ID: 19109042
[TBL] [Abstract][Full Text] [Related]
7. Canine transmissible venereal tumour: a review.
Ganguly B; Das U; Das AK
Vet Comp Oncol; 2016 Mar; 14(1):1-12. PubMed ID: 23981098
[TBL] [Abstract][Full Text] [Related]
8. Use of exfoliative cytology for diagnosis of transmissible venereal tumour and controlling the recovery period in the bitch.
Erünal-Maral N; Findik M; Aslan S
Dtsch Tierarztl Wochenschr; 2000 May; 107(5):175-80. PubMed ID: 10887668
[TBL] [Abstract][Full Text] [Related]
9. Vincristine for treatment of transmissible venereal tumor in the dog--.
Calvert CA; Leifer CE; MacEwen EG
J Am Vet Med Assoc; 1982 Jul; 181(2):163-4. PubMed ID: 6749780
[No Abstract] [Full Text] [Related]
10. Chemotherapeutic management of transmissible venereal tumors in 30 dogs.
Brown NO; Calvert C; MacEwen EG
J Am Vet Med Assoc; 1980 May; 176(10 Pt 1):983-6. PubMed ID: 7380719
[TBL] [Abstract][Full Text] [Related]
11. Vincristine modulates the expression of Ki67 and apoptosis in naturally occurring canine transmissible venereal tumor (TVT).
Özalp GR; Zik B; Bastan A; Peker S; Özdemir-Salci ES; Bastan I; Darbaz I; Salar S; Karakas K
Biotech Histochem; 2012 Jul; 87(5):325-30. PubMed ID: 22404564
[TBL] [Abstract][Full Text] [Related]
12. Semen quality during vincristine treatment in dogs with transmissible venereal tumor.
Saratsis P; Ypsilantis P; Tselkas K
Theriogenology; 2000 Mar; 53(5):1185-92. PubMed ID: 10798495
[TBL] [Abstract][Full Text] [Related]
13. Primary intranasal transmissible venereal tumour in the dog: a retrospective study of six spontaneous cases.
Papazoglou LG; Koutinas AF; Plevraki AG; Tontis D
J Vet Med A Physiol Pathol Clin Med; 2001 Sep; 48(7):391-400. PubMed ID: 11599677
[TBL] [Abstract][Full Text] [Related]
14. Ocular manifestations of canine transmissible venereal tumour: a retrospective study of 25 cases in Greece.
Komnenou AT; Thomas AL; Kyriazis AP; Poutahidis T; Papazoglou LG
Vet Rec; 2015 May; 176(20):523. PubMed ID: 25888603
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy using intratumoral bacillus Calmette-Guerin (BCG) and vincristine in dogs with transmissible venereal tumours: therapeutic efficacy and histological changes.
Mukaratirwa S; Chitanga S; Chimatira T; Makuleke C; Sayi ST; Bhebhe E
J S Afr Vet Assoc; 2009 Jun; 80(2):92-6. PubMed ID: 19831270
[TBL] [Abstract][Full Text] [Related]
16. Canine transmissible venereal tumor and seminoma: a cytohistopathology and chemotherapy study of tumors in the growth phase and during regression after chemotherapy.
Javanbakht J; Pedram B; Taheriyan MR; Khadivar F; Hosseini SH; Abdi FS; Hosseini E; Moloudizargari M; Aghajanshakeri SH; Javaherypour S; Shafiee R; Emrani Bidi R
Tumour Biol; 2014 Jun; 35(6):5493-500. PubMed ID: 24557542
[TBL] [Abstract][Full Text] [Related]
17. Measurement of the rate of death of canine transmissible venereal tumour cells transplanted into dogs and nude mice.
Holmes JM
Res Vet Sci; 1981 Mar; 30(2):248-50. PubMed ID: 7255917
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral recombinant human interferon alpha-2a and vincristine combination therapy in canine transmissible venereal tumour.
Kanca H; Tez G; Bal K; Ozen D; Alcigir E; Atalay Vural S
Vet Med Sci; 2018 Nov; 4(4):364-372. PubMed ID: 30117719
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous transmissible venereal tumor without genital involvement in a prepubertal female dog.
Marcos R; Santos M; Marrinhas C; Rocha E
Vet Clin Pathol; 2006 Mar; 35(1):106-9. PubMed ID: 16511800
[TBL] [Abstract][Full Text] [Related]
20. Cell cycle kinetics, apoptosis rates and gene expressions of MDR-1, TP53, BCL-2 and BAX in transmissible venereal tumour cells and their association with therapy response.
Flórez MM; Fêo HB; da Silva GN; Yamatogi RS; Aguiar AJ; Araújo JP; Rocha NS
Vet Comp Oncol; 2017 Sep; 15(3):793-807. PubMed ID: 26879698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
